Not Applicable.
Not Applicable.
1. Field of the Invention
This invention relates generally to therapeutic ultrasound devices and, more particularly, to an apparatus and method for mounting a therapeutic device to an orthopaedic cast or other medical wrapping.
2. Related Art
The use of ultrasound to therapeutically treat and evaluate bone injuries is known. Impinging ultrasonic pulses having appropriate parameters, e.g., frequency, pulse repetition, and amplitude, for suitable periods of time and at a proper external location adjacent to a bone injury has been determined to accelerate the natural healing of, for example, bone breaks and fractures. For patients with reduced healing capacity, such as elderly persons with osteoporosis, ultrasonic therapy may promote healing of bone injuries that would otherwise require prosthetic replacement or leave the patient permanently disabled.
The ultrasound therapy is often used in conjunction with medical wraps, such as an orthopaedic cast. A rigid or semi-rigid plastic transducer port is mounted onto a fracture cast allowing its use for all large and small bones. Providing reliable bonding of the port into the cast with minimal increase in elevation and radius is highly desirable. Currently, reliance is placed on the adhesive properties of the cast resin in shear to bond the port to the cast. This is a disadvantage as a shear bond is not as strong as other types of bonding.
Another problem associated with the prior art transducer mounting apparatus becomes apparent to physicians during the installation of the apparatus. Typically, a cast will be mounted on the patient prior to the time that the decision is made to administer ultrasound therapy. Therefore, the physician is required to cut a hole in the existing cast to accommodate placement of an ultrasound transducer head module adjacent a body portion of a patient requiring treatment. Because a substantial number of transducer head modules are circular, a corresponding circular hole is required in the cast. However, physicians are commonly equipped with a tool having a blade that may be adjusted to limit penetration to the depth of the cast to cut a square or rectangular void in the cast. Moreover, it is inefficient to require the physician to be concerned with the precision with which the void is made in the cast. Therefore, a need exists for an apparatus that can be placed within a void in a cast and convert the square or rectangular void to a circular hole for receiving an ultrasound transducer head module and also an apparatus that is adaptable and versatile to minimize a precision associated with the dimensions of the void.
Typically, an ultrasonic therapy device may be applied to a cast in one of three ways. First, a medical practitioner may cut a hole in the cast and strap an ultrasonic transducer directly over the hole. Second, the medical practitioner may cut a hole in the cast and force fit a plastic transducer port into the cast, and then place the ultrasonic transducer in the port. Third, the medical practitioner may build a cast around a plastic transducer port and thereafter mount the ultrasonic transducer in the port.
Alternatively, the physician may know, at the time the injury occurs, that ultrasound therapy is likely a preferred future treatment. However, the installation of a spacer which creates a void in the cast has heretofore been delayed until a period of time has elapsed such that the danger of swelling around the affected injury site has transpired, because it has been determined that the skin within the void is prone to window edema (especially during the swelling period). Therefore, a need exists for an apparatus that allows the surgeon to install an insert or support fixture in the cast at the time of injury which will insertably receive an ultrasound transducer treatment head module and also prevent window edema when the module is not in place.
There remains a need in the art for an improved assembly for accurately mounting and positioning a therapeutic treatment device onto a cast that overcomes the above-noted disadvantages, is easy to use, and provides better results in healing musculoskeletal and bone injuries.
It is in view of the above problems that the present invention was developed. According to an aspect of the invention there is provided an apparatus for ultrasonically treating an injury in conjunction with an orthopaedic cast. The apparatus includes: a portable self-contained main operating unit; a support fixture configured and adapted for attachment to the orthopaedic cast adjacent an external site corresponding to an internal injury remote from the main operating unit, the support fixture having a body and at least one mesh projection extending from the body; an ultrasonic transducer treatment head module operatively connected to the main operating unit and detachably engaged with the body of the support fixture; and casting material for attaching the support fixture to the orthopaedic cast, wherein at least a portion of the casting material impregnates the at least one mesh projection.
In one embodiment of the invention, the at least one mesh projection comprises a planar mesh base.
In another embodiment of the invention, the at least one mesh projection comprises a plurality of mesh tabs.
In another embodiment of the invention, the at least one mesh projection further comprises at least one living hinge.
In yet another embodiment of the invention, the at least one mesh projection conforms to a small radius of curvature.
In one particular embodiment of the invention, the main operating unit has an internal power source and is dimensioned to be carried by a patient during treatment.
In another embodiment of the invention, the treatment head module has an ultrasonic signal generator and signal generator circuitry operatively associated therewith.
In yet another embodiment of the invention, the treatment head module comprises an ultrasound transducer.
In still another embodiment of the invention, the ultrasound transducer has piezoelectric properties and is made from a material selected from the group consisting of a ceramic material, a single-crystal relaxor ferroelectric, lead zirconate titanate, lead metaniobate, barium titanate, and piezoelectric co-polymers of polyvinylidene fluoride (PVDF).
In another embodiment of the invention, the treatment head module is connected to the main operating unit through a wireless connection.
In one particular embodiment of the invention, the main operating unit has an ultrasonic signal generator and signal generator circuitry, wherein the signal generator circuitry includes a processor, a pulsed signal generator, and a switch coupled to the processor for regulating the pulsed signal.
In another embodiment of the invention, the main operating unit has a display panel coupled to the signal generator circuitry to display treatment sequence data and a keypad coupled to the signal generator circuitry to permit user control of the signal generator.
In another embodiment of the invention, there is provided an optical transmitter connected to the switch, the optical transmitter being configured to convert the pulsed signal to an optical signal.
In yet another embodiment of the invention, there is provided a communication interface connected between a communication port and the processor to provide a communication link between the ultrasonic signal generator and an external computer/modem.
In still another embodiment of the invention, there is provided an alarm connected to the processor to indicate accurate compliance with a treatment protocol.
In one particular embodiment of the invention, the body of the support fixture has an aperture configured to receive a portion of the ultrasonic transducer treatment head module.
In another embodiment of the invention, the body has at least two bayonet lugs extending into the aperture which are electrically connected to form a conductive path therebetween.
In yet another embodiment of the invention, the ultrasonic transducer treatment head module includes at least two slotted lugs having at least a portion thereof extending from an outer surface of the module and configured to engage the at least two bayonet lugs, the at least two slotted lugs being fabricated from conductive plastic such that when the slotted lugs engage the bayonet lugs a conductive path is formed between the slotted lugs.
In another embodiment of the invention, the support fixture has an outer surface and an inner surface defining an axial bore therethrough with a proximal inlet and a distal outlet.
In yet another embodiment of the invention, there is provided a spacer configured to fit within a void in the orthopaedic cast, the spacer having an opening therein, the opening having a shape corresponding to an outer periphery of the support fixture, and the support fixture being at least partially positioned within the opening. In one particular embodiment of the invention, the spacer is formed of felt.
In another embodiment of the invention, there is provided an ultrasound transmission-enhancing medium positioned within the body. In one particular embodiment of the invention, the ultrasound transmission-enhancing medium is a gel pad.
In another embodiment of the invention, there is provided a locking structure on an outside periphery of the body.
In still another embodiment of the invention, the body extends upwardly in a transverse direction relative to the at least one mesh projection.
In yet another embodiment of the invention, there is provided a cap attached to the body and a biasing element connected to the cap, wherein the biasing element engages the ultrasonic transducer treatment head module.
In another embodiment of the invention, the body is a cylindrical hollow tube.
In yet another embodiment of the invention, the body further comprises a lip.
In still another embodiment of the invention, the body has a proximal end portion and a distal end portion, and the at least one mesh projection is located at the distal end portion.
In another embodiment of the invention, the casting material comprises at least one cast material strip.
In yet another embodiment of the invention, the support structure further comprises a hemispherical notch.
In another embodiment of the invention, the mesh projection is made from a material selected from the group consisting of a polymer or a composite. In one particular embodiment of the invention, the polymer is selected from the group consisting of thermoplastic polymers, thermosetting polymers, and elastomers. In another embodiment of the invention, the polymer is made of a fourteen count polyester core yarn having a vinyl coating.
In one particular embodiment of the invention, the mesh projection is made from a material selected from the group consisting of polyvinyl chloride, polyethylene, acrylonitrile butadiene styrene, or silicone.
In another embodiment of the invention, the mesh projection has a thickness A, and the thickness A is in the range from about one-half millimeter to about seven millimeters. In one particular embodiment of the invention, the thickness A is about one millimeter.
In another embodiment of the invention, the mesh projection has a first dimension D1 and a second dimension D2, and the first dimension D1 is in the range from about twenty-five millimeters to about one hundred fifty millimeters, and the second dimension D2 is in the range from about twenty-five millimeters to about one hundred fifty millimeters. In one particular embodiment of the invention, D1 and D2 are each about 57 millimeters.
In another embodiment of the invention, the body is rigid or semi-rigid.
In another embodiment of the invention, a portion of the mesh projection is constructed of a material that may be seen with a chosen medical visualizing system.
In another embodiment of the invention, a portion of the mesh projection is at least partially opaque to X-radiation.
In another embodiment of the invention, a portion of the mesh projection is at least partially opaque to infra-red radiation.
In another embodiment of the invention, a portion of the mesh projection is at least partially paramagnetic.
In another embodiment of the invention, a portion of the mesh projection includes an adhesive coating.
In another embodiment of the invention, the mesh projection further comprises one or more peripheral markers. In one particular embodiment of the invention, there are four peripheral markers. In another embodiment of the invention, the peripheral markers are selected from the group consisting of a radio-opaque thread woven into the mesh, radio-opaque ink, cut pieces of lead tape.
In another embodiment of the invention, there is provided a central marker.
In another embodiment of the invention, the mesh projection has a varying weave spacing.
In another embodiment of the invention, the support fixture has a concave lower end.
In another embodiment of the invention, the support fixture includes at least one circumferential groove in an upper portion thereof.
In another embodiment of the invention, the support fixture includes at least one circumferential flange.
In another embodiment of the invention, the support fixture features locking structure on the outside periphery of the body.
In another embodiment of the invention, the locking structure includes a circumferential ridge on the outside periphery of the support fixture which is configured to engage at least one locking member extending downward from an outer periphery of a cover. In one particular embodiment of the invention, there are three locking members.
In another embodiment of the invention, the locking member is formed of a resilient material such that it will flex outward as the ridge thereon is forced over ridge, and it will snap back into position after it moves beyond ridge.
In another embodiment of the invention, there is provided a support fixture configured and adapted for attachment to a medical wrap adjacent an external site corresponding to an internal injury, the support fixture comprising: a body, the body having an inner wall and an outer wall, the inner wall forming an opening adapted to receive, in use, an ultrasonic therapy device; and at least one mesh projection, the at least one mesh projection extending from the body and having a plurality of openings, and wherein at least a portion of the plurality of openings is impregnated with a portion of the medical wrap.
The invention has several advantages over prior devices and techniques. First, the apparatus has increased strength in comparison to existing ports due to the impregnation of the mesh projection by the casting material, such as resin. Second, the mesh projection provides the ability to use the fixture on smaller radius limbs. Third, the mesh projection allows for a reduction in size of the cast opening, thereby reducing the possibility of cast failure.
Thus, in furtherance of the above goals and advantages, the present invention is, briefly, a rigid or semi-rigid transducer body with a flexible mesh or weave projection which enables conformation to a small radius of curvature, for example, around a limb or finger. The weave is sufficiently open to allow resin impregnation through the weave for incorporation of the transducer body to the cast. The resin impregnated weave does not rely on shear properties (which are weaker) for attachment to the cast but instead relies on the strength of the resin in tension and compression as the resin passes through the weave and attaches to the cast.
Further features, aspects, and advantages of the present invention, as well as the structure and operation of various embodiments of the present invention, are described in detail below with reference to the accompanying drawings.
The accompanying drawings, which are incorporated in and form a part of the specification, illustrate embodiments of the present invention and together with the description, serve to explain the principles of the invention. In the drawings:
Referring to the accompanying drawings in which like reference numbers indicate like elements,
Referring to
Communication port 34 is affixed to printed circuit board 22 and accessible through channel 36 in housing 20. Communication port 34 is coupled to signal generator circuitry 38 on printed circuit board 22 and provides a communication link, e.g., for serial communications, between the MOU 12 and an external computer. In this configuration, a physician can download information, such as the number, date, time of day, and/or duration of actual treatments initiated by the patient, stored within signal generator circuitry 38.
Processor 44 is also utilized to control the treatment sequence, i.e., the start time and the stop time of the ultrasonic treatment. The processor may be preprogrammed for treatment times and the user (e.g. the physician or patient) selects one of the treatment times via keypad 31, or the processor may be programmed by the user via keypad 31 to set the start and stop sequence. Treatment times may range between about one and about sixty minutes, although treatments in the order of 10-20 minutes are typical. When the treatment time is activated, processor 44 closes switch 60 which permits the modulated signal to pass to cable 16. When the treatment time expires, switch 60 is opened and the modulated signal is inhibited from passing to cable 16. In addition, when the treatment time expires, processor 44 may send an alarm signal to alarm 62 which activates.
Referring to
An alternative embodiment of the transducer treatment head module circuitry is shown in
The logic voltage converter 76 steps down the voltage for the microprocessor and other electronics. The power source 77 supplies power to the ultrasonic treatment apparatus 10′ and may be a battery or battery pack. The battery voltage sense circuitry 78 senses the power of the power source 77 and prevents operation if there is insufficient power to drive the transducer and the other electronic components. The drive signal voltage converter 79 steps down the voltage for the transducer drive circuitry 84. The drive signal voltage adjustor 80 is used to calibrate the transducer drive circuitry 84 to obtain a predetermined acoustic wave from the transducer 85. The real time clock 81 is the clock for the microprocessor 88. The EEPROM 82 is used to record data after a treatment. Such data may include date, time, length of treatment, and other variables.
The gel sense circuitry 83 senses an impedance change through the transducer to ascertain whether the transducer is emitting acoustic waves into a fluid or gel medium. Every transducer has an impedance when it is acting on a medium, such as air or water. The impedance is different for each medium. By using this difference, the gel sense circuitry 83 can determine whether or not the transducer is acting upon a gel medium.
The transducer drive circuitry 84 creates the sinusoidal wave that drives the transducer 85. The ultrasound transducer 85 creates the ultrasonic wave for treating the injury. The first user interface 86 is a display. The first user interface 86 may indicate items such as time duration, and errors. The second user interface 87 is one or more switches that are used to control the ultrasonic treatment apparatus 10′. Such switches may include a start button, a stop button, and a reset button. The microprocessor 88 executes stored programs to apply the treatment in a predefined manner.
Further, some embodiments of the ultrasonic treatment apparatus 10′ eliminate the wired connection between the transducer drive circuitry 84 and the ultrasound transducer 85 and instead implement a wireless connection, such as ZIGBEE™, BLUETOOTH™, IEEE 802.11, or other Radio Frequency (RF) technology. ZigBee is a published specification set of high level communication protocols designed for wireless personal area networks (WPANs). The ZIGBEE trademark is owned by ZigBee Alliance Corp., 2400 Camino Ramon, Suite 375, San Ramon, Calif., U.S.A. 94583. Bluetooth is a technical industry standard that facilitates short range communication between wireless devices. The BLUETOOTH trademark is owned by Bluetooth Sig, Inc., 500 108th Avenue NE, Suite 250, Bellevue Wash., U.S.A. 98004. IEEE 802.11 denotes a set of Wireless LAN/WLAN standards developed by working group 11 of the IEEE LAN/MAN Standards Committee (IEEE 802). RF is a wireless communication technology using electromagnetic waves to transmit and receive data using a signal above approximately 0.1 MHz in frequency.
The base 112 is made of a mesh or woven material. The mesh or weave allows the base 112 to conform to a small radius of curvature. For example, the mesh or weave permits the base to conform to a small limb or finger. Further, the mesh or weave aids in the incorporation of the support fixture 110 to a cast 288 (best seen in
As explained in greater detail below, the mesh or weave captures a portion of the cast resin, which strengthens the attachment of the support structure to the cast in comparison to prior devices. Prior devices utilized shear properties to retain the support structure to the cast. Impregnating the mesh or weave with resin permits the present invention to utilize shear, tension, and compression characteristics to adhere the support structure to the cast. This is a significant improvement over the state of the art.
The base 112 may be made from many different types of materials, such as a polymer or a composite. Polymers may include thermoplastic polymers, thermosetting polymers, and elastomers. Examples of polymers may include, among others, polyvinyl chloride, polyethylene, acrylonitrile butadiene styrene, or silicone. In the embodiment depicted in
The body 114 is rigid or semi-rigid. The body 114 is shaped to receive the transducer 120. The transducer 120 is constructed of materials and designs that are commonly used in ultrasound applications. The transducer 120 may have piezoelectric properties and may be made from, as examples, a ceramic material, a single-crystal relaxor ferroelectric, lead zirconate titanate, lead metaniobate, barium titanate, and piezoelectric co-polymers of polyvinylidene fluoride (PVDF). Alternatively, the transducer 120 may have magnetostrictive properties.
In the embodiment depicted in
A cap 116 is connected to the body 114 at the distal end portion 136. For example, the body 114 may have a lip 140 (best seen in
A system controller 122 spatially and temporally controls the acoustic waves that emanate from the transducer 120. The design and fabrication of the system controller 122 are well known to those who practice the art. The system controller 122 is electrically connected to a signal generator 124, and the signal generator 124 is electrically connected to the transducer 120. The system controller 122 triggers the programmable signal generator 124 to produce ultrasonic excitation signals that are sent to the transducer 120. The transducer 120 receives the excitation signal and emits an acoustic longitudinal wave that propagates on to medium B. The system controller 122 and the signal generator 124 may take the form of the MOU 12 described above.
The transducer 120 produces specific sequential or simultaneous transmissions of acoustic waves, which is controlled by the system controller 122, in order to non-invasively irradiate or interrogate the medium B ultrasonically. The system controller 122 may be a programmable microprocessor, but may also include, though is not limited to, integrated circuits, analog devices, programmable logic devices, personal computers or servers. The timing sequences may be established by the user at any time or established during the manufacturing process.
The ultrasonic transducer assembly 100 may be used to administer therapeutic treatment composed of an ultrasound dosage administered once or twice a day, and repeated daily for several months to effectively stimulate the healing process. In some embodiments, one dosage of acoustic waves ranges between one and sixty minutes in length for the transducer 120. The ultrasonic transducer assembly 110 may be used to facilitate and enhance application of therapeutic ultrasound dosages to shallow or deep anatomical structures, or both, in an effort to expedite tissue wound healing, including both the endosteal and periosteal healing phases in the bone fracture healing process.
Referring now to
The dimensions of the ring 280 are typically a function of the size of the patient, the estimated size and location of the injury, and the type of visualizing system used. For example, to determine the location of a bone fracture in an average human limb, e.g., the ulna or radius, and using an X-ray imaging system, the diameter of the ring may nominally be about thirty-eight millimeters. In this example, the ring may be a rigid torus of metallic material of cross-sectional diameter nominally five millimeters. As another example, if the visualization system utilized is an ultrasonic imaging system, the ring 280 may be substantially flexible and planar, so that it may contour to a surface it is placed adjacent to, thereby allowing the scanning or imaging transducer to be moved across the surface and the ring.
As noted, the strap 282 has two sections 284 and 286, each section has one end fastened to the ring 280. The two sections 284 and 286 may have hook and loop type fastening assembly, such as VELCRO™, so that they may be fastened together and quickly unfastened. Other quick release fastening techniques are also contemplated.
Alternatively, a portion of the mesh base 112 may be used to identify the location of injured bone. Thus, a portion of the mesh base 112 may be constructed of a material that may be seen with a chosen medical visualizing system. For example, if X-rays are used, a portion of the mesh base 112 is at least partially opaque to X-radiation. If infra-red radiation is used, a portion of the mesh base 112 is at least partially opaque to infra-red radiation, and, if magnetic resonance imaging is used, a portion of the mesh base 112 is at least partially paramagnetic. However, the other materials may be used for the mesh base 112 which permits detection by medical visualizing or imaging systems. Additionally, the mesh base 112 may have an adhesive coating on one side for temporarily locating the mesh base 112 while the medical visualizing system is activated.
An external image, e.g., an X-ray, of the fractured region is taken to include the locating ring 280. Although the initial position of the locating ring 280 with respect to the bone injury is a preliminary approximation, in many instances the initial placement will be sufficiently accurate so that the X-ray will depict the bone injury framed by the ring 280. The resulting X-ray image indicates the position of the bone injury relative to the locating ring 280. The X-rays are used as a guide to locate and mark 290 the corresponding point on the cast relative to the actual locating ring 280. The mark 290 gives an approximate external location on the cast of the bone injury. If greater accuracy is required, the ring 280 may be centered about the mark 290, another X-ray is taken, and a new mark (not shown) is made on the cast based on the location of the bone fracture relative to the ring on the X-ray. Successive iterations of repositioning the locating ring 280 and X-raying the site will yield even greater accuracy.
As noted above, in some embodiments, the mesh base 112 may be used instead of the ring 280 in order to locate the mark 290.
As shown in
The template 292, and consequently the opening 294 in the cast 288, is smaller than the mesh base 112 of the fixture 110 for retaining and aligning the ultrasonic transducer assembly 14, so that the mesh base 112 engages the cast surface surrounding the opening 294 when the fixture 110 is placed over the opening 294. The fixture 110 includes the circular aperture 134 and may include bayonet locking lugs 306. Aperture 134 has substantially the same diameter as the cylindrical felt pad 298.
In some embodiments, a portion of the mesh base 112 includes an adhesive. The adhesive may be used to temporarily affix the mesh base 112 to the cast until resin impregnates the mesh and affixes the mesh base 112 in a more permanent manner.
Referring to
In some embodiments, the mesh base 112 may be used as a template to cut the opening 294.
In yet other embodiments, the opening 294 may be cut free-hand. In other words, the opening 294 may be cut without a template. Once the opening 294 is cut, the mesh base 112 is trimmed with scissors or some other cutting device to match the shape of the mesh base 112 with the opening 294.
Referring again to
The operative surface 318 of transducer treatment head module 14 includes a gel sensing element for confirming the presence of ultrasonic conductive material on the operative surface 318. This surface 318 is pre-coated with a coupling gel before it is inserted in the fixture 110 and engages the skin. Alternatively, the gel may be contained adjacent the operative surface 318 of transducer treatment head module 14 using a gel sack, gel bladder or like container.
Spacer 530 maintains fixture 520 at a predetermined distance from the body portion 534 of a patient, to prevent window edema or a similar injury to the patient due to uneven pressure at a casted site. As shown, fixture 520 is partially inserted into the hole within spacer 530 and is supported thereon by at least one of the radially extending mesh tabs 526. Mesh tabs 526 contain living hinges formed by a reduction in cross-section of the mesh tabs 526 at a proximal end adjacent the bore of fixture 520 which weakens mesh tabs 526 at the hinge point, thus allowing them to bend freely. The living hinges provide for lateral flexure of mesh tabs 526 to enhance the ability to conform to varying angles which are a function of the anatomy of the patient. Moreover, the living hinges allow fixture 520 to be articulated to correct for other angular misalignments.
Fixture 520 is secured within void 522 in cast 524 by weaving strips 532 of cast material between mesh tabs 526. A plurality of layers of cast material strips 532 are placed around fixture 520 until a desired thickness is achieved. Further, due to its mesh nature, the cast material impregnates the openings of the mesh tabs 526, thereby increasing the structural attachment of the fixture 520 to the cast 524. The configuration of fixture 520 having mesh tabs 526 allows the fixture to be installed before or after the cast is installed. Advantageously, when the layers of cast material strips cure, fixture 520 will be an integral part of the cast. Thus, any impact on the skin of the patient, which would otherwise be transferred through fixture 520, will be minimized as it is absorbed by the cast.
Fixture 520 may optionally include a hemispherical notch 536 in an upper end thereof to accommodate a cord extending from an ultrasound treatment head module while the module is positioned within the fixture. A lower end 538 of fixture 520 is preferably concave to correspond to fit a convex body portion 534 of a patient, without impacting the skin which may cause edema or a similar injury.
An ultrasound transmission-enhancing medium 528 is preferably positioned within spacer 530 adjacent a treatment location to minimize or eliminate an air gap between an ultrasound transducer head module and a treatment location. The ultrasound transmission-enhancing medium 528 is preferably a conductive gel bladder but may be simply gel.
The apparatus of the present invention is configured to adapt to and fit within a substantially rectangular or square-shaped void in a cast as shown in a top view thereof in
Turning now to the exploded side view in
An ultrasound transducer head module 544 is positioned adjacent ultrasound transmission-enhancing medium 528 within fixture 520. Cord 550 connects module 544 with electronic driving circuitry. Housing 546 is then inserted in the upper portion of fixture 520 to enclose the components within fixture 520. A bias element 548 extends from a bottom portion of housing 546. Bias element 548 may be a spring and, more particularly, may be a conical helical spring. The conical helical spring is advantageously configured to fully collapse within itself and will therefore require less space within fixture 520. A conical helical spring will also maintain a uniform force on ultrasound transducer head module 544 and will allow module 544 to pivot to conform to the shape of transmission-enhancing medium 528.
Referring to
Conical helical spring 618 is held in contact with a lower surface of cover 616 by resilient housing 620. Resilient housing 620 is designed to maintain spring 618 in its position under cover 616 while exhibiting resiliency corresponding to the compressive property of spring 618. Housing 620 is secured to cover 616 by lock ring 622 which may be affixed to cover 616 by epoxy or any other means known to one having ordinary skill in the art. Housing 620 is preferably formed of polyurethane having a thickness of about 0.01 inches to about 0.10 inches.
Also illustrated in
Similar to cover 616 illustrated in
Additionally, as an alternative to the internal locking structure illustrated in
The pre-cast installation of apparatus 670 will now be described with reference to
Turning now to
The invention also includes a method of mounting a therapeutic device to an orthopaedic cast. The method includes the steps of: providing a support fixture, the support fixture comprising a body and a mesh projection extending from the body; placing a mark on the orthopaedic cast; making an opening in the orthopaedic cast relative to the mark; placing the support fixture over the opening; and placing cast material over the support fixture and the cast such that a portion of the cast material at least partially impregnates the mesh projection of the support fixture. Optionally, the support fixture further comprises an adhesive coating applied to the mesh base, and the adhesive coating is used to temporarily affix the mesh base to the cast until a portion of the cast material at least partially impregnates the mesh base. The method may further include the steps of locating a bone fracture and the step of placing a locating ring and strap on a cast. Alternatively, the method may include the step of placing a support fixture having peripheral markers on a cast. The method also may include the step of engaging a medical visualizing system. The method may further include the step of marking the opening relative to the mark using a template. Alternatively, the method may further include the step of marking the opening relative to the mark using the support fixture. The step of marking the opening relative to the mark using a template may include the step of outlining peripheral slots of the template. Alternatively, the step of marking the opening relative to the mark using the support fixture may include the step of placing adhesive tape over the support fixture and the cast.
In some embodiments, the invention may comprise a kit for ultrasonically treating injuries while maintaining patient mobility. The kit includes a support fixture configured and adapted to be worn by a patient adjacent an external site of an internal injury, the support fixture having a mesh base and a body extending from the mesh base; an ultrasonic transducer treatment head module including an ultrasonic signal generator and detachably engaged with the body of the support fixture; and a portable self-contained main operating unit operatively connected to the treatment head module. The body of the support fixture may include an aperture configured to receive a portion of the ultrasonic transducer treatment head module. Further, the body may include one or more bayonet lugs extending into the aperture, which are electrically connected to form a conductive path therebetween. The ultrasonic transducer treatment head module may include one or more slotted lugs having at least a portion thereof extending from an outer surface of the transducer treatment head module and configured to engage the at least two bayonet lugs, the at least two slotted lugs being fabricated from conductive plastic such that when the slotted lugs engage the bayonet lugs a conductive path is formed between the slotted lugs. The ultrasonic signal generator may include signal generator circuitry and an internal power source connected to the signal generator circuitry, a display coupled to the signal generator circuitry to display treatment sequence data, a keypad coupled to the signal generator circuitry to permit user control and/or entry of data, the signal generator circuitry including a processor, a pulse RF signal generator, and a switch coupled to the processor for regulating the pulsed RF signal. Some embodiments of the kit may include a communication interface connected between a communication port and the processor to provide a communication link between the ultrasonic signal generator and an external computer. Additionally, some embodiments may include a cap engagable with the support fixture to replace the ultrasonic transducer treatment head module when the module is not being used for treatment. The may include a pad configured and adapted to be positioned between the cap and a skin surface of the patient for applying a predetermined pressure to the skin surface.
In view of the foregoing, it will be seen that the several advantages of the invention are achieved and attained.
The embodiments were chosen and described in order to best explain the principles of the invention and its practical application to thereby enable others skilled in the art to best utilize the invention in various embodiments and with various modifications as are suited to the particular use contemplated.
As various modifications could be made in the constructions and methods herein described and illustrated without departing from the scope of the invention, it is intended that all matter contained in the foregoing description or shown in the accompanying drawings shall be interpreted as illustrative rather than limiting. For example, while many illustrations depict the mesh base as having a rectangular shape, those of ordinary skill in the art would understand that the mesh base may have any number of shapes. Thus, the breadth and scope of the present invention should not be limited by any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims appended hereto and their equivalents.
This application is a divisional of U.S. patent application Ser. No. 12/092,849, filed May 7, 2008, which is a National Phase of International Application No. PCT/US2006/60628, filed Nov. 7, 2006, which claims the benefit of U.S. Provisional Application No. 60/734,245, filed Nov. 7, 2005. The disclosures of the prior applications are incorporated by reference in their entirety.
Number | Date | Country | |
---|---|---|---|
60734245 | Nov 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12092849 | May 2008 | US |
Child | 13447561 | US |